Chemometric applications of naïve bayesian models in drug discovery: Beyond compound ranking

Chemoinformatics for Drug Discovery

Volumn , Issue , 2013, Pages 131-148

  Lounkine, Eugen ^a   Kutchukian, Peter S ^a   Glick, Meir ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Decision making; Molecular similarity; Na ve Bayesian model; Target prediction

Indexed keywords

BIOACTIVITY; DECISION MAKING; OUTSOURCING;

ADVERSE DRUG REACTION (ADRS); BAYESIAN APPROACHES; BAYESIAN MODEL; CHEMICAL AND BIOLOGICALS; MOLECULAR SIMILARITY; PHENOTYPIC SCREENING; SIMILARITY METRICS; TARGET PREDICTION;

BAYESIAN NETWORKS;

EID: 85016031495     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118742785.ch7     Document Type: Chapter

References (43)

1. Glick M, Klon AE, Acklin P, et al. J Biomol Screen 2004;9:32-36.
2. Glick M, Jacoby E. Curr Opin Chem Biol 2011;15:540-546.
3. Mayr LM, Bojanic D. Curr Opin Pharmacol 2009;9:580-588.
4. Nidhi MG, Davies JW, Jenkins JL. J Chem Inf Model 2006;46:1124-1133.
5. Rogers D, Brown RD, Hahn M. J Biomol Screen 2005;10:682-686.
6. Xia X, Maliski EG, Gallant P et al. J Med Chem 2004;47:4463-4470.
7. Crisman TJ, Bender A, Milik M, et al. J Med Chem 2008:51:2481-2491.
8. Biniashvili T, Schreiber E, Kliger Y. J Chem Inf Model 2012;52:678-685.
9. Vogt M, Godden JW, Bajorath J. J Chem Inf Model 2007;47:39-46.
10. Kappler MA. Curr Opin Drug Discov Devel 2008;11:389-392.
11. Bender A, Glen RC. Org Biomol Chem 2004;2:3204-3218.
12. Bender A. Methods Mol Biol 2011:672:175-196.
13. Hu Y, Lounkine E, Bajorath J. Chem Biol Drug Des 2009;74:92-98.
14. Bender A, Jenkins JL, Glick M, et al. J Chem Inf Model 2006;46:2445-2456.
15. Tiikkainen P, Franke L. J Chem Inf Model 2012;52:319-326.
16. Kido H, Okumura Y, Takahashi E, et al. Biochim Biophys Acta 2012;1824:186-194.
17. Bhargava KP, Dixit KS, Palit G. Br J Pharmacol 1976;57:211-213.
18. Curran ME, Splawski I, Timothy KW, et al. Cell 1995;80:795-803.
19. Rothman RB, Baumann MH, Savage JE, et al. Circulation 2000;102:2836-2841.
20. Hamon J, Whitebread S, Techer-Etienne V, et al. Future Med Chem 2009;1:645-665.
21. Nigsch F, Lounkine E, McCarren P, et al. Expert Opin Drug Metab Toxicol 2011;7: 1497-1511.
22. Rogers D, Hahn M. J Chem Inf Model 2010;50:742-754.
23. Watson P. J Chem Inf Model 2008;48:166-178.
24. Sun H. J Med Chem 2005;48:4031-4039.
25. Vogt M, Bajorath J. Chem Biol Drug Des 2008;71:8-14.
26. Glick M, Jenkins JL, Nettles JH, et al. J Chem Inf Model 2006;46:193-200.
27. Chen B, Sheridan RP, Hornak V, et al. J Chem Inf Mod 2012;52:792-803.
28. Wawer M, Lounkine E, Wassermann AM, et al. Drug Discov Today 2010;15:630-639.
29. Wang Y, Bajorath J. J Chem Inf Model 2008;48:75-84.
30. Scior T, Bender A, Tresadern G, et al. J Chem Inf Model 2012;52:867-881.
31. Lounkine E, Nigsch F, Jenkins JL, et al. J Chem Inf Model 2011;51:3158-3168.
32. Heller S, McNaught A, Stein S, et al. J Cheminform. 2013;5:7.
33. Williams AJ, Ekins S. Drug Discov Today 2011;16:747-750.
34. Gaulton A, Bellis LJ, Bento AP, et al. Nucleic Acids Res 2011;40(Database issue): D1100-1107.
35. Scheiber J, Jenkins JL, Sukuru SCK, et al. J Med Chem 2009;52:3103-3107.
36. van Hoorn WP, Bell AS. J Chem Inf Model 2009;49:2211-2220.
37. Sukuru SCK, Nigsch F, Quancard J, et al. Protein Sci. 2010;19:2096-2109.
38. Yildirim MA, Goh K-I, Cusick ME, et al. Nat Biotechnol 2007;25:1119-1126.
39. Keiser MJ, Roth BL, Armbruster BN, et al. Nat Biotechnol 2007;25:197-206.
40. Niijima S, Shiraishi A, Okuno Y. J Chem Inf Model 2012;52:901-912.
41. Gleeson P, Bravi G, Modi S, et al. Bioorg Med Chem 2009;17:5906-5919.
42. Kutchukian P, Vasilyeva NY, Xu J, et al. PLoS One. 2012;7:e48476.
43. Konenko I. Semi-naive Bayesian classifier. EWSL-91: Proceedings of the European Working Session on Learning on Machine Learning. Heidelberg: Springer; 1991. p 206-219.